Noah Miller-Medzon

Noah Miller-Medzon is an experienced scientist specializing in process development, currently serving as a Scientist II at Lexeo Therapeutics since September 2021. Previously, Noah was a Molecular Virology Technician Manager at Mirimus, where a key achievement included the development of a SARS-CoV-2 qPCR testing pipeline capable of processing 20,000 tests daily, aiding various organizations in resuming operations. Noah also collaborated internationally on the creation of a novel isothermal CRISPR SARS-CoV-2 assay. Prior to Mirimus, Noah worked at LogicBio Therapeutics as a Research Associate focused on vector development and downstream processing, optimizing production pathways and mastering various aspects of the drug product lifecycle. Noah holds a Bachelor of Arts in Biology and Theater from Wesleyan University and has also participated in programs at The School for Field Studies.